menu search

Could amgen's heart disease candidate generate billions in sales?

Amgen recently shared positive clinical trial results for a heart disease drug candidate....

December 11, 2022, 9:15 am

Fate therapeutics highlights ipsc-derived, off-the-shelf car nk cell programs for multiple myeloma at 2022 ash annual meeting

Interim Phase 1 Data of FT576 BCMA-targeted Product candidate Show Clinical Activity in Initial Single-...

December 10, 2022, 7:46 pm

Fate therapeutics announces clinical safety and activity data of first-ever ipsc-derived car t-cell therapy at 2022 ash annual meeting

FT819 Off-the-Shelf CAR T-cell Product candidate Derived from Clonal Engineered Master iPSC Line with N...

December 10, 2022, 3:00 pm

In fx talent wars, demand gives candidates the upper hand

According to Glassdoor (which collates salary data submitted anonymously), the average base salary for an ...

December 10, 2022, 5:30 am

Graphite bio: underfollowed gene editing play at an attractive valuation

Graphite Bio has lost roughly 60% of its value over the past twelve months and is trading with a negative enterprise value despite its prospects in ge...

December 9, 2022, 9:19 pm

Synaptogenix: bryostatin for alzheimer's, as binary as can be

Synaptogenix has announced a readout of a Phase 2 randomized placebo-controlled trial in Alzheimer's disease for the current quarter. Preclinical work...

December 9, 2022, 11:50 am

Arcellx flies on $325m deal with gilead's kite for multiple myeloma treatment

Arcellx shares soared in early trade after the clinical-stage biotechnology company announced a global strategic collaboration with Gilead Sciences' K...

December 9, 2022, 11:42 am

Why is baudax bio (bxrx) stock up 46% today?

Baudax Bio (NASDAQ: BXRX ) stock is rocketing higher on Friday after the pharmaceutical company initiated a Phase 2 clinical trial of BX1000. BX1000 i...

December 9, 2022, 9:48 am

Gilead to co-develop arcellx's multiple myeloma drug

Gilead Sciences Inc. GILD, +1.91% said Friday that it will co-develop and co-commercialize Arcellx Inc.'s ACLX, +7.22% multiple myeloma treatment ...

December 9, 2022, 8:46 am

Pfizer and biontech get fda fast track designation for single-dose covid and flu vaccine candidate

Pfizer Inc. PFE, +3.07% and German partner BioNTech SE BNTX, +5.64% said Friday they have received fast track designation from the U.S. Food and Drug ...

December 9, 2022, 6:54 am

Gossamer bio: buying the savage dip after a trial 'win' may be unwise

Gossamer Bio, Inc.'s lead candidate - Seralutinib, indicated for Pulmonary Arterial Hypertension - met ...

December 8, 2022, 1:27 pm

Vodafone rumour mill swirls with potential names for new ceo

Lots of potential candidates are being touted as the potential new Vodafone Group PLC (LSE:VOD) boss on...

December 8, 2022, 12:21 pm

Pfizer (pfe) rsv vaccine candidate bla gets fda's priority tag

The FDA's decision on Pfizer's (PFE) BLA seeking approval for RSV vaccine candidate in older adults is ...

December 8, 2022, 12:03 pm

Allergy therapeutics doses first patient in 'pivotal' hay fever trial

Allergy Therapeutics said it had dosed its first patient in a phase III trial for a new grass pollen vaccine, while screening is underway for a safety...

December 8, 2022, 2:39 am

Karuna: acquisition prospects thin with ceo change

Karuna Therapeutics, Inc. transitioned a new CEO in yesterday, with the former chief now president of R&D. Questions now arise on Karuna Therapeutics'...

December 7, 2022, 3:37 pm

Prometheus biosciences soars as new data indicates therapeutic candidate holds promise for bowel disease

Prometheus Biosciences Inc shares have rocketed more than 170% on positive results for its therapeutic candid<...

December 7, 2022, 12:07 pm

Fda expected to decide on pfizer rsv vaccine for older adults by may 2023

Pfizer said the FDA has accepted its RSV vaccine candidate for review under an expedited process that r...

December 7, 2022, 10:37 am

Biovie updates investors on its alzheimer's and parkinson's clinical programs

BioVie Inc (NASDAQ:BIVI) said it has made significant progress with its clinical programs, including its drug ...

December 7, 2022, 9:08 am

7 nasdaq stocks to buy and hold forever

The Nasdaq stocks are known as high-flying growth plays, not necessarily buy-and-hold candidates. Elect...

December 6, 2022, 5:52 pm

Recruiter.com enters into strategic partnership with talent

Recruiter.com Group, Inc. (NASDAQ:RCRT) has announced a strategic partnership with Talent Inc, a leading career services company providing a job seeke...

December 6, 2022, 10:15 am


Search within

Pages Search Results: